📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis. (2022)

First Author: Giamberardino CD

Attributed to: Rational Design, Synthesis and Biological Evaluation of Benzimidazoles; Towards a Novel Therapy Selectively Targeting C. neoformans beta-tubulin funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/mbio.02347-22

PubMed Identifier: 36222509

Publication URI: http://europepmc.org/abstract/MED/36222509

Type: Journal Article/Review

Volume: 13

Parent Publication: mBio

Issue: 6